Attached files
| file | filename |
|---|---|
| 10-Q - QUARTERLY REPORT - Icagen, Inc. | f10q0612_caldera.htm |
| EX-31.1 - CERTIFICATION - Icagen, Inc. | f10q0612ex31i_caldera.htm |
| EX-31.2 - CERTIFICATION - Icagen, Inc. | f10q0612ex31ii_caldera.htm |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Caldera Pharmaceuticals, Inc. (the "Registrant") on Form 10-Q for the period ending June 30, 2012 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Benjamin Warner, certify, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to Section. 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.
|
/s/ Benjamin Warner
|
|
|
Benjamin Warner
Chief Executive Officer and
Chief Financial Officer
(Principal Executive Officer and
Principal Accounting Officer)
|
August 10, 2012